TKD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Takeda Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 29.63 EUR -2.08% Market Closed

Market Cap: €47.1B

	Takeda Pharmaceutical Co Ltd F:TKD	JP
	Dufry AG F:D2J	CH
	SB Financial Group Inc F:9KH	US
A	Atmos Energy Corp F:AEO	US
N	NVIDIA Corp XMUN:NVD	US
	Clas Ohlson AB F:OHCB	SE
I	IPD Group Ltd ASX:IPG	AU
S	Standard Chartered PLC XBER:STD	UK

Profitability Summary

Takeda Pharmaceutical Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

65%

Strong 3Y Average Gross Margin

66%

Declining Gross Margin

69% > 65%

Low Operating Margin

Sustainable 3Y Average Operating Margin

10%

Declining Operating Margin

13% > 3%

Negative Net Margin

-4%

Low 3Y Average Net Margin

Declining Net Margin

7% > -4%

Exceptional Free Cash Flow Margin

11%

Strong 3Y Average Free Cash Flow Margin

12%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.